The Board of the National Securities Market Commission (CNMV) announced that has approved, at its meeting held today, the voluntary takeover bid for the shares of Clínica Baviera, S.A. submitted by Aier Eye International (Europe), S.L.U.
The offer is aimed at 100% of the share capital of Baviera composed of 16,307,580 shares of 0.10 euros par value, excluding 1,630,758 shares (10% of the share capital), which have been immobilized. Therefore, the bid effectively extends to the acquisition of 14,676,822 shares representing 90% of the share capital of Baviera.
The purchase price offered is 10.35 euros per share to accept the offer and has been set by the offeror in accordance with the provisions on fair price of Article 9 of the Royal Decree on takeover bids.
The offeror has agreements in place with six shareholders of Baviera, owners of 69.35% of the share capital, by virtue of which they irrevocably undertake to accept the offer with 59.35% of the share
capital and immobilize the remaining 10%.
By way of a guarantee, a guarantee has been submitted amounting to 151,905,107.70 euros issued by BNP Paribas Sucursal en España.
The acceptance period for the bid is 30 calendar days from the trading day following the publication of the first announcement with the essential data of the bid, also ending on a trading day.
The prospectus and supporting documents, which shall be incorporated into the public records of CNMV, may be consulted at least from the trading day following the publication of the first announcement with the essential data of the bid.